Tekmira Pharmaceuticals Corp (TKMR) (TKMR)

[surf1944]

8:01AM Tekmira Pharma provides update on U.S. Government sponsored TKM-Ebola program; funding has been increased by $6.9 mln, from $34.8 mln to $41.7 mln for the first phase of the contract (TKMR) 4.73 : Co announced that its contract with the U.S. Department of Defense (DoD) has been modified to support development plans that integrate advancements in Tekmira's lipid nanoparticle (LNP) formulation and manufacturing technologies, and provide for additional funding for the TKM-Ebola program.

TKM-Ebola, an anti-Ebola viral therapeutic, is being developed under a contract with the U.S. DoD's Joint Project Manager Transformational Medical Technologies (JPM-TMT) Office with a total contract value of ~$140 million.